Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2005 Feb;31(2):123-8; discussion 128.
doi: 10.1111/j.1524-4725.2005.31030.

Immediate and midterm complications of sclerotherapy: report of a prospective multicenter registry of 12,173 sclerotherapy sessions

Affiliations
Multicenter Study

Immediate and midterm complications of sclerotherapy: report of a prospective multicenter registry of 12,173 sclerotherapy sessions

Jean-Jérôme Guex et al. Dermatol Surg. 2005 Feb.

Abstract

Background: Growing interest in sclerotherapy has emphasized the need for complete knowledge of all aspects of this method.

Objective: To precisely delineate the actual incidence of immediate and delayed untoward events of daily sclerotherapy.

Methods: A multicenter prospective registry was established in 22 phlebology clinics to report their activity and complications.

Results: During the study period, 12,173 sessions of sclerotherapy were carried out, 5,434 with liquid, 6,395 with foam, and 344 using both. Four thousand eighty-eight (33.9%) sessions were carried out with ultrasound guidance. Forty-nine incidents or accidents (0.4%) occurred, of which 12 were with liquid and 37 with foam. These were reported during the time of the study and an additional 1-month follow-up. Most numerous were 20 cases of visual disturbances (in 19 cases, foam or air block was used); all resolved shortly, without any after-effects. A femoral vein thrombosis was the only severe adverse event in this study.

Conclusions: This study demonstrates that sclerotherapy is a safe technique.

PubMed Disclaimer

Publication types

MeSH terms

Substances